Jefferies Financial Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,578
Closed -$247K – 1662
2026
Q2
$247K Buy
+1,578
New +$237K ﹤0.01% 1427
2026
Q1
– Sell
-4,606
Closed -$635K – 2075
2025
Q4
$635K Buy
+4,606
New +$603K ﹤0.01% 1258
2024
Q1
– Sell
-49,437
Closed -$4.99M – 1895
2023
Q4
$4.99M Buy
+49,437
New +$4.77M 0.03% 406

Other funds holding NVS

Jefferies Financial Group's NVS Position: Q3 2026 in Review

Jefferies Financial Group sold out of Novartis (NVS) in Q3 2026, closing a stake of 1,578 shares — an estimated $247K sold.

Jefferies Financial Group first reported a position in NVS in Q4 2023 and held it in 3 quarters. The position peaked at $4.99M in Q4 2023. 1,370 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Jefferies Financial Group reported no remaining Novartis position as of Q3 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 1,578 Novartis shares in Q3 2026, an estimated $247K.
  • Jefferies Financial Group first reported a position in Novartis in Q4 2023 and held it in 3 quarters.
  • Jefferies Financial Group's Novartis position peaked at $4.99M in Q4 2023.
  • 1,370 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.